Literature DB >> 19205138

Drug expenditure in Ireland 1997-2007.

M Barry1, D Molloy, C Usher, L Tilson.   

Abstract

Community prescribing accounts for approximately 85% of total drug expenditure. In 2007 spending on medicines under the Community Drugs Schemes exceeded Euro 1.74 billion, a five-fold increase over the decade 1997-2007. The year on year increase in spending on medicines is amongst the highest in Europe. The desire of the HSE to reduce or at least contain drug expenditure is appreciated and is consistent with approaches across other EU member states. Recent developments in drug pricing and reimbursement as outlined here may help to contain the drugs bill. However, the emergence of promising but expensive biologic agents for cancer therapy and other chronic conditions threaten any cost containment measures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19205138

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  4 in total

1.  Pharmacoeconomic evaluation in Ireland: a review of the process.

Authors:  Lesley Tilson; Aisling O'Leary; Cara Usher; Michael Barry
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Ageing, health status and coverage rate effects on community prescription costs in Ireland.

Authors:  Martin Kenneally; Brenda Lynch
Journal:  Eur J Health Econ       Date:  2017-06-21

3.  The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026.

Authors:  Aisling Conway; Martin Kenneally; Noel Woods; Andreas Thummel; Marie Ryan
Journal:  BMC Health Serv Res       Date:  2014-10-21       Impact factor: 2.655

4.  Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland.

Authors:  A O'Leary; C Usher; M Lynch; M Hall; L Hemeryk; S Spillane; P Gallagher; M Barry
Journal:  BMC Res Notes       Date:  2015-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.